Enterome Revenue and Competitors
Estimated Revenue & Valuation
- Enterome's estimated annual revenue is currently $15.7M per year.
- Enterome's estimated revenue per employee is $155,000
- Enterome's total funding is $128.9M.
Employee Data
- Enterome has 101 Employees.
- Enterome grew their employee count by 6% last year.
Enterome's People
| Name | Title | Email/Phone |
|---|---|---|
1 | Head Finance | Reveal Email/Phone |
2 | Head Immunology research | Reveal Email/Phone |
3 | Head Regulatory Affairs | Reveal Email/Phone |
4 | Head Clinical Operations | Reveal Email/Phone |
5 | Head Metasecretome Research | Reveal Email/Phone |
6 | Head Drug Discovery | Reveal Email/Phone |
7 | Data Scientist | Reveal Email/Phone |
8 | Chief Financial Officer | Reveal Email/Phone |
9 | Chief Medical Officer | Reveal Email/Phone |
10 | Human Resources Director | Reveal Email/Phone |
Enterome Competitors & AlternativesAdd Company
| Competitor Name | Revenue | Number of Employees | Employee Growth | Total Funding | Valuation |
|---|---|---|---|---|---|
#1 | $81.4M | 375 | 40% | N/A | N/A |
#2 | $16.9M | 109 | 22% | N/A | N/A |
#3 | $156.1M | 120 | -70% | $145M | N/A |
#4 | $2.9M | 37 | -24% | $150M | N/A |
#5 | $1.3M | 17 | 0% | $459.5M | N/A |
#6 | $49.2M | 254 | 15% | $180.7M | N/A |
#7 | $7M | 45 | -2% | N/A | N/A |
#8 | $256.3M | 840 | 9% | $168.5M | N/A |
#9 | $4.2M | 27 | -7% | N/A | N/A |
#10 | $10.1M | 65 | 5% | N/A | N/A |
What Is Enterome?
Enterome is a clinical stage company, pioneering the development of novel pharmaceuticals and diagnostics to support personalized therapies in microbiome-related diseases such as Inflammatory Bowel Disease (IBD), cancer and metabolic diseases. Enterome is also leading the development of new industry standards in gut microbiome quantitative and functional analysis. This technology leadership allows Enterome to open up the new field of therapeutic target discovery in the microbiome in order to address significant unmet medical needs. Enterome has established partnerships with leading pharmaceutical companies and academic research institutes, including Johnson & Johnson Innovation/Janssen Biotech, Takeda and Abbvie in inflammatory bowel and gastro-intestinal diseases; Bristol-Myers Squibb in immuno-oncology; and the Mayo Clinic and Geisinger hospitals in metabolic disorders. The Company was established in 2012 in Paris (France) to develop drugs and diagnostics from its proprietary metagenomic platform and is backed by leading venture capital investors (Seventure Partners, Lundbeckfonden Ventures, Health for Life Capital & Omnes Capital) as well as strategic investors (Nestlￃﾃￂﾩ Health Science, BMS, Shire & INRA Transfert).
keywords:N/A
$128.9M
Total Funding
101
Number of Employees
$15.7M
Revenue (est)
6%
Employee Growth %
N/A
Valuation
N/A
Accelerator
Enterome News
Enterome Bioscience, E.I. Du Pont De Nemours and Company, Merck & Co. Metabiomics Corporation, Yakult Honsha Co.
Vedanta, Seres Therapeutics, Second Genome, Rebiotix, ActoGeniX, Enterome BioScience, AvidBiotics, 4D Pharma Research Ltd, Enterologics,...
Enterome is a clinical-stage biopharmaceutical company focused on developing breakthrough immunomodulatory drugs for the treatment of cancer and...
Enterome has received a €46.3 million investment. New backers SymBiosis and Takeda Pharmaceutical joined the round, alongside existing investors. The French business develops therapies for cancer, autoimmune, inflammatory and metabolic diseases. The capital will be used to fund clinical trials. ...
Other Companies in
| Company Name | Revenue | Number of Employees | Employee Growth | Total Funding |
|---|---|---|---|---|
#1 | $14.1M | 101 | N/A | N/A |
#2 | $14.6M | 101 | N/A | N/A |
#3 | $13.1M | 101 | N/A | N/A |
#4 | $10.1M | 101 | 0% | N/A |
#5 | $14.1M | 101 | 28% | N/A |